Nisa Investment Advisors
PRME icon

Nisa Investment Advisors’s Prime Medicine PRME Stock Holding History

Nisa Investment Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8K Sell
4,544
-4,802
-51% -$15.9K ﹤0.01% 2298
2026
Q1 		$32.5K Buy
9,346
+4,800
+106% +$18.3K ﹤0.01% 1846
2025
Q4 		$15.8K Sell
4,546
-55,900
-92% -$249K ﹤0.01% 2035
2025
Q3 		$335K Buy
60,446
+56,210
+1,327% +$228K ﹤0.01% 1134
2025
Q2 		$10.5K Buy
4,236
+3,921
+1,245% +$6.04K ﹤0.01% 2242
2025
Q1 		$627 Sell
315
-12,301
-98% -$31.4K ﹤0.01% 2753
2024
Q4 		$36.8K Buy
12,616
+12,507
+11,474% +$43.9K ﹤0.01% 1765
2024
Q3 		$422 Sell
109
-7,627
-99% -$35.3K ﹤0.01% 2750
2024
Q2 		$39.8K Buy
7,736
+7,702
+22,653% +$46.7K ﹤0.01% 1730
2024
Q1 		$238 Buy
34
+10
+42% +$76 ﹤0.01% 2612
2023
Q4 		$213 Buy
24
+4
+20% +$31 ﹤0.01% 2543
2023
Q3 		$191 Sell
20
-13
-39% -$169 ﹤0.01% 2673
2023
Q2 		$483 Buy
+33
New +$461 ﹤0.01% 2568

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nisa Investment Advisors's PRME Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Prime Medicine (PRME) stake by 51% in Q2 2026, selling an estimated $15.9K and leaving 4,544 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2298.

Nisa Investment Advisors first reported a position in PRME in Q2 2023 and has held it in 13 quarters since. The position peaked at $335K in Q3 2025. 68 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Nisa Investment Advisors held 4,544 shares of Prime Medicine worth $16.8K as of Q2 2026.
  • Nisa Investment Advisors sold 4,802 Prime Medicine shares in Q2 2026, an estimated $15.9K.
  • Prime Medicine made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2298 holding.
  • Nisa Investment Advisors first reported a position in Prime Medicine in Q2 2023 and has held it in 13 quarters since.
  • Nisa Investment Advisors's Prime Medicine position peaked at $335K in Q3 2025.
  • 68 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.